Constraining the expression of nicotinic acetylcholine receptors by using pentameric constructs.
about
Using concatenated subunits to investigate the functional consequences of heterotetrameric inositol 1,4,5-trisphosphate receptorsProgress and challenges in the study of α6-containing nicotinic acetylcholine receptors.Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.Use of concatemers of ligand-gated ion channel subunits to study mechanisms of steroid potentiation.Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variantTandem couture: Cys-loop receptor concatamer insights and caveats.Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.What single-channel analysis tells us of the activation mechanism of ligand-gated channels: the case of the glycine receptor.The molecular architecture of the arachidonate-regulated Ca2+-selective ARC channel is a pentameric assembly of Orai1 and Orai3 subunits.Expression of water-soluble, ligand-binding concatameric extracellular domains of the human neuronal nicotinic receptor alpha4 and beta2 subunits in the yeast Pichia pastoris: glycosylation is not required for ligand bindingHow to validate a heteromeric ion channel drug target: assessing proper expression of concatenated subunits.A GABA(A) receptor of defined subunit composition and positioning: concatenation of five subunits.Deletion of the nicotinic acetylcholine receptor subunit gene Dα1 confers insecticide resistance, but at what cost?Concatenated nicotinic acetylcholine receptors: A gift or a curse?
P2860
Q26852168-10EA859A-2288-4B4B-9C78-DAC46276D3D0Q33954007-15872AB2-6B5C-42A8-BD16-27C5CFAA6023Q33991060-890C20D0-92A7-4644-911B-345473FD8644Q34458500-809E9825-BCD0-4145-A0B5-640E05B04BBDQ35581094-9A36FE98-9274-41A9-BCDD-AE8602AE776FQ36126982-74C17FAD-D371-4309-B5F9-C8AD8BDCC9BAQ36829293-8AC3F516-D3EB-4DC0-8BA6-A0E62176B219Q36890894-F2356DBA-9DF0-47F8-BFB5-E9F47F938F7DQ37230743-DAFB36BA-FCCB-4E86-B761-4ABB452DC0EEQ37601095-9B21ADCF-9FCE-4076-8787-97DF3E1B88ECQ39822490-77F64927-D260-4273-A83F-4C0AB836CE25Q42112580-D781D0AB-50C4-4AD8-ABC0-40CFFE1F4517Q43183322-4A5C4BD3-A1C9-428F-BF16-93F8A4B7FDC4Q46957801-9855BA07-0993-47A0-ADBA-34BA23C20061Q47666838-33F468E6-07EB-4079-8D6F-22CA7C49D5C4Q47703691-5BA663DA-F127-45BB-BBA1-0A7CDB8A577A
P2860
Constraining the expression of nicotinic acetylcholine receptors by using pentameric constructs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Constraining the expression of ...... y using pentameric constructs.
@en
Constraining the expression of ...... y using pentameric constructs.
@nl
type
label
Constraining the expression of ...... y using pentameric constructs.
@en
Constraining the expression of ...... y using pentameric constructs.
@nl
prefLabel
Constraining the expression of ...... y using pentameric constructs.
@en
Constraining the expression of ...... y using pentameric constructs.
@nl
P50
P356
P1476
Constraining the expression of ...... y using pentameric constructs.
@en
P2093
Paul J Groot-Kormelink
P304
P356
10.1124/MOL.105.019356
P577
2005-11-03T00:00:00Z